Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey.
Fauvel C, Bonnet G, Mullens W, Giraldo CIS, Mežnar AZ, Barasa A, Tokmakova M, Shchendrygina A, Costa FM, Mapelli M, Zemrak F, Tops LF, Jakus N, Sultan A, Bahouth F, Hadjseyd CE, Salvat M, Anselmino M, Messroghli D, Weberndörfer V, Giverts I, Bochaton T, Courand PY, Berthelot E, Legallois D, Beauvais F, Bauer F, Lamblin N, Damy T, Girerd N, Sebbag L, Pezel T, Cohen-Solal A, Rosano G, Roubille F, Mewton N. Fauvel C, et al. Among authors: legallois d. Eur J Heart Fail. 2023 Feb;25(2):213-222. doi: 10.1002/ejhf.2743. Epub 2022 Nov 23. Eur J Heart Fail. 2023. PMID: 36404398 Free article.
CRT-D replacement strategy: results of the BioCONTINUE study.
Gras D, Clémenty N, Ploux S, Guyomar Y, Legallois D, Segreti L, Blangy H, Laurent G, Bizeau O, Fauquembergue S, Lazarus A; BioCONTINUE study Investigators. Gras D, et al. Among authors: legallois d. J Interv Card Electrophysiol. 2023 Aug;66(5):1201-1209. doi: 10.1007/s10840-022-01440-5. Epub 2022 Dec 2. J Interv Card Electrophysiol. 2023. PMID: 36459310
Clinical outcomes for 2788 patients with transthyretin amyloidosis: Tafamidis meglumine early access program in France.
Lairez O, Réant P, Inamo J, Jeanneteau J, Bauer F, Habib G, Eicher JC, Lequeux B, Legallois D, Josse C, Hippocrate A, Bartoli M, Dubois M, Noirot Cosson C, Squara PA, Fievez S, Quinault A, Rudant J, Kharoubi M, Damy T. Lairez O, et al. Among authors: legallois d. Arch Cardiovasc Dis. 2024 Oct 5:S1875-2136(24)00323-1. doi: 10.1016/j.acvd.2024.08.006. Online ahead of print. Arch Cardiovasc Dis. 2024. PMID: 39426850
Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database.
Alexandre J, Font J, Angélique DS, Delapierre B, Damaj G, Plane AF, Legallois D, Milliez P, Dolladille C, Chrétien B. Alexandre J, et al. Among authors: legallois d. Leukemia. 2024 Dec;38(12):2628-2635. doi: 10.1038/s41375-024-02413-5. Epub 2024 Sep 19. Leukemia. 2024. PMID: 39300222 Free PMC article.
Rationale and design of the French Observatory of Acute Heart Failure (OFICA2).
Bouleti C, Alos B, Legallois D, Eschalier R, Costa J, Tea V, Trochu JN, Turlotte G, Perrin-Faurie J, Dutoiu T, Picard F, Ducrocq G, de Groote P, Laperche T, Delmas C, Cohen A, Doublet M, Logeart D. Bouleti C, et al. Among authors: legallois d. Arch Cardiovasc Dis. 2024 Aug-Sep;117(8-9):514-520. doi: 10.1016/j.acvd.2024.05.120. Epub 2024 Jul 4. Arch Cardiovasc Dis. 2024. PMID: 39089898
Recurrent acute myocarditis: An under-recognized clinical entity associated with the later diagnosis of a genetic arrhythmogenic cardiomyopathy.
Ollitrault P, Al Khoury M, Troadec Y, Calcagno Y, Champ-Rigot L, Ferchaud V, Pellissier A, Legallois D, Milliez P, Labombarda F. Ollitrault P, et al. Among authors: legallois d. Front Cardiovasc Med. 2022 Oct 28;9:998883. doi: 10.3389/fcvm.2022.998883. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36386348 Free PMC article.
64 results